E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 12/15/2005 in the Prospect News Biotech Daily.

JMP initiates Align at market perform

Align Technology, Inc. coverage was initiated by JMP Securities analyst Anthony Ostrea at a market perform rating. The stock is off 43% from its 52-week high of $12, but JMP said it believes uncertainty regarding revenue growth due to competition on OrthoClear will limit share price appreciation. JMP said it will await stabilization of growth drivers before getting more positive on the name. Shares of the Santa Clara, Calif., maker of Invisalign for malocclusion were down 1 cent, or 0.15%, at $6.80 on volume of 373,197 shares versus the three-month running average of 616,035 shares.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.